Amara Sarwal

Nephrology

220 Millpond Ste 100
Stansbury Park, UT 84074

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Cardiorenal Syndrome and Depressive Symptoms: Exploring the Mood-Kidney Link With Heart Failure Risk in a Post-hoc Analysis of SPRINT.

Cardiorenal Syndrome and Depressive Symptoms: Exploring the Mood-Kidney Link With Heart Failure Risk in a Post-hoc Analysis of SPRINT.

Journal: Kidney medicine

Published: June 30, 2026

Impact of automatic e-consults on use of SGLT2i and GLP-1 RA in rural veterans with type 2 diabetes and chronic kidney disease.

Impact of automatic e-consults on use of SGLT2i and GLP-1 RA in rural veterans with type 2 diabetes and chronic kidney disease.

Journal: Primary care diabetes

Published: January 30, 2026

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 1: introduction to a new series.

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 1: introduction to a new series.

Journal: Kidney international

Published: January 16, 2026

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 1: introduction to a new series.

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 1: introduction to a new series.

Journal: Kidney international

Published: January 16, 2026

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 2: from initiation to publication: the KDIGO guideline development process.

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 2: from initiation to publication: the KDIGO guideline development process.

Journal: Kidney international

Published: January 15, 2026

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 4: translating evidence into KDIGO guideline statements.

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 4: translating evidence into KDIGO guideline statements.

Journal: Kidney international

Published: January 14, 2026

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 3: evidence synthesis for guideline development: the KDIGO approach.

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 3: evidence synthesis for guideline development: the KDIGO approach.

Journal: Kidney international

Published: January 14, 2026

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 6: bridging the gap between guidelines and clinical practice: the KDIGO approach to global implementation and education in nephrology.

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 6: bridging the gap between guidelines and clinical practice: the KDIGO approach to global implementation and education in nephrology.

Journal: Kidney international

Published: January 14, 2026

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 5: guideline updates and a living model for the future.

Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 5: guideline updates and a living model for the future.

Journal: Kidney international

Published: January 14, 2026

Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes.

Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes.

Journal: JAMA network open

Published: October 13, 2025

Just Do It- Exercise before or during Hemodialysis.

Just Do It- Exercise before or during Hemodialysis.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: August 12, 2025

Comparative Effectiveness of SGLT2 Inhibitor and GLP-1 Receptor Agonist on Kidney and Cardiovascular Outcomes by Kidney Failure Risk.

Comparative Effectiveness of SGLT2 Inhibitor and GLP-1 Receptor Agonist on Kidney and Cardiovascular Outcomes by Kidney Failure Risk.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 30, 2025

Showing 1-12 of 36

Last Updated: 09/26/2026